{"id":70723,"date":"2026-05-12T09:57:27","date_gmt":"2026-05-12T09:57:27","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70723"},"modified":"2026-05-21T07:14:10","modified_gmt":"2026-05-21T07:14:10","slug":"kisspeptin-10","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/kisspeptin-10\/","title":{"rendered":"Kisspeptine-10"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is Kisspeptin-10?<\/h3>\n<p style=\"margin: 0;\"><strong>Kisspeptine-10<\/strong> (KP-10) is a 10-amino-acid C-terminally amidated peptide and the most-studied active fragment of the KISS1 gene product. It is the apical endogenous regulator of GnRH neuronal activity \u2014 published research established it as the upstream switch that initiates puberty and drives pulsatile gonadotropin release. Acts via the GPR54 (KISS1R) G-protein-coupled receptor. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials for laboratory research use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Wat u krijgt bij MedsBase:<\/strong> Onderzoekskwaliteit lyofiliseerde peptiden \u00b7 HPLC \u226599% zuiverheid (COA op aanvraag) \u00b7 Discrete temperatuurstabiele verpakking \u00b7 Wereldwijde peptidekoerier \u00b7 1.400+ geverifieerd <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">klantbeoordelingen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Elke bestelling is gedekt door onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specificatie<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">374675-21-5 (kisspeptin-10, human)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molecuulformule<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>63<\/sub>H<sub>83<\/sub>N<sub>17<\/sub>O<sub>14<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Moleculair gewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1302.45 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequentie<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH<sub>2<\/sub> (YNWNSFGLRF-NH<sub>2<\/sub>, 10 amino acids; C-terminally amidated active fragment of the 54-aa mature kisspeptin)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliseerd poeder (wit tot off-white)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Zuiverheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC geverifieerd, COA op aanvraag)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Opslag<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliseerd: 2\u20138 \u00b0C (koelkast) voor werkvoorraad; \u221220 \u00b0C voor langdurige opslag van ongeopende flesjes. Gereconstitueerd: 2\u20138 \u00b0C, gebruik binnen ~30 dagen. Bescherm tegen licht. Vries de gereconstitueerde oplossing niet in en ontdooi deze niet.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Oplosbaarheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatisch water (aanbevolen) of steriel water voor kortere gebruiksperioden<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Onderzoeksgebruik<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Alleen voor laboratoriumonderzoek. Niet voor humaan of veterinair diagnostisch of therapeutisch gebruik.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>What Is Kisspeptin-10?<\/h2>\n<p><strong>Kisspeptine-10<\/strong> (KP-10) is a 10-amino-acid peptide and the most extensively studied active fragment of the KISS1 gene product, a 145-amino-acid preprokisspeptin that is processed into the 54-amino-acid mature kisspeptin and several shorter C-terminal active fragments (kisspeptin-14, kisspeptin-13, kisspeptin-10). All of the shorter fragments share the C-terminal 10-residue active core and have comparable potency at the kisspeptin receptor \u2014 kisspeptin-10 is the shortest fully active form and is by far the most common research peptide in the kisspeptin literature.<\/p>\n<p>The well-characterised sequence is YNWNSFGLRF-NH<sub>2<\/sub>, molecular weight 1302.45\u00a0Da, empirical formula C<sub>63<\/sub>H<sub>83<\/sub>N<sub>17<\/sub>O<sub>14<\/sub>. The C-terminal amidation is essential for full receptor activity. KISS1 was originally identified as a metastasis-suppressor gene by Lee et al. (Cancer Res 1996) and was renamed kisspeptin in honour of Hershey, Pennsylvania (home of Hershey&#8217;s Kisses chocolates) where the gene was first cloned. The reproductive role \u2014 KISS1\/GPR54 as the apical regulator of GnRH neurons and the molecular gatekeeper of puberty \u2014 was established by two independent papers in 2003 (Seminara et al., NEJM; de Roux et al., PNAS) demonstrating that loss-of-function GPR54 mutations cause idiopathic hypogonadotropic hypogonadism in humans. Kisspeptin-10 is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. It is <strong>niet goedgekeurd<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use, although ongoing IVF and infertility research is investigating clinical applications. The research-grade kisspeptin-10 sold here is supplied <strong>uitsluitend voor laboratoriumonderzoek<\/strong> and is not intended for human or veterinary administration.<\/p>\n<h2>Mechanism of Action \u2014 GPR54 \/ KISS1R Signalling and the HPG Axis<\/h2>\n<p>What makes kisspeptin-10 mechanistically distinctive among reproductive-research peptides is its position as the <strong>apical upstream regulator<\/strong> of the entire hypothalamic-pituitary-gonadal (HPG) axis. The peptide acts at a single receptor \u2014 GPR54 (also called KISS1R) \u2014 but the downstream cascade controls the full reproductive endocrine system in published research:<\/p>\n<ul>\n<li><strong>GPR54 (KISS1R) activation on GnRH neurons<\/strong> \u2014 Kisspeptin-10 binds GPR54, a class A G-protein-coupled receptor expressed densely on GnRH neuron cell bodies in the hypothalamic arcuate and anteroventral periventricular nuclei. Receptor activation couples to G\u03b1<sub>q\/11<\/sub> and phospholipase C, raising intracellular calcium and triggering GnRH neuron depolarisation and pulsatile GnRH release into the hypophyseal portal system. This is the most direct mechanism \u2014 GnRH neuron firing is the rate-limiting step of HPG-axis activity, and kisspeptin is the principal endogenous stimulus.<\/li>\n<li><strong>Pulsatile vs surge-mode HPG-axis regulation<\/strong> \u2014 Kisspeptin neurons in the arcuate nucleus drive the pulsatile GnRH\/LH pattern that maintains gonadal function throughout adult reproductive life. A separate population of kisspeptin neurons in the anteroventral periventricular nucleus (in rodents) generates the preovulatory LH surge in females. Research using selective stimulation or knockout of these populations has dissected the two modes of HPG-axis output in published research.<\/li>\n<li><strong>Puberty initiation and the &#8220;kisspeptin switch&#8221;<\/strong> \u2014 Loss-of-function GPR54 mutations cause complete failure of puberty onset in humans and animal models; gain-of-function mutations cause central precocious puberty. The &#8220;kisspeptin switch&#8221; hypothesis \u2014 that puberty is initiated when arcuate kisspeptin neurons reach a critical activity threshold \u2014 is the dominant model of pubertal onset in current reproductive neuroscience research.<\/li>\n<\/ul>\n<p>Kisspeptin-10 has a relatively short plasma half-life (~5\u201310 minutes) due to rapid proteolytic cleavage, particularly at the central RF amide motif by matrix metalloproteinases. Subcutaneous, intravenous, and intracerebroventricular routes are all documented in published research; the central route is reserved for mechanism-of-action studies in rodents where the BBB-crossing question is relevant. For systemic HPG-axis research, peripheral administration produces measurable GnRH\/LH responses within minutes of bolus injection.<\/p>\n<h2>Gepubliceerde onderzoeksapplicaties<\/h2>\n<p>Kisspeptin-10 is used in laboratory research contexts that investigate:<\/p>\n<ul>\n<li><strong>Reproductive endocrinology and HPG-axis pharmacology<\/strong> \u2014 pulsatile GnRH\/LH\/FSH dynamics, gonadal feedback regulation, sex-steroid feedback on kisspeptin neuron activity (Seminara et al., NEJM 2003; de Roux et al., PNAS 2003)<\/li>\n<li><strong>Puberty research<\/strong> \u2014 pubertal onset timing in rodent models, kisspeptin-neuron activation patterns across the pubertal transition, mechanistic dissection of central precocious puberty<\/li>\n<li><strong>Hypogonadotropic hypogonadism research<\/strong> \u2014 preclinical models of GPR54 loss-of-function, kisspeptin-replacement protocols, mechanism-of-action research for novel hypogonadism therapies<\/li>\n<li><strong>IVF and ovulation induction research<\/strong> \u2014 alternatives to hCG trigger in IVF protocols, comparative LH-surge induction; clinical translation has reached Phase 2 in some research programmes although kisspeptin-10 itself is not approved<\/li>\n<li><strong>Polycystic ovary syndrome (PCOS) research<\/strong> \u2014 altered kisspeptin tone in PCOS preclinical models, LH-pulse frequency abnormalities, follicular maturation research<\/li>\n<li><strong>Metastasis suppression and cancer biology<\/strong> \u2014 KISS1 was originally identified as a metastasis-suppressor gene; published research continues to investigate kisspeptin&#8217;s anti-metastatic activity in breast, melanoma, and pancreatic cancer models<\/li>\n<li><strong>Cardiovascular and metabolic research<\/strong> \u2014 emerging KISS1R expression on cardiomyocytes and pancreatic \u03b2-cells; effects on glucose homeostasis and cardiac contractility under investigation<\/li>\n<li><strong>Comparative reproductive peptide research<\/strong> \u2014 benchmarking tegen <a href=\"https:\/\/medsbase.com\/nl\/pt-141\/\">PT-141 (Bremelanotide)<\/a> for melanocortin-axis sexual-behaviour research and against <a href=\"https:\/\/medsbase.com\/nl\/oxytocin-acetate\/\">Oxytocine Acetaat<\/a> for affiliative and social-bonding endpoints.<\/li>\n<\/ul>\n<p>For broader context on where kisspeptin-10 fits within the reproductive and CNS-active peptide landscape, see <a href=\"https:\/\/medsbase.com\/nl\/pt-141\/\">PT-141<\/a> (melanocortin agonist for sexual behaviour research), <a href=\"https:\/\/medsbase.com\/nl\/oxytocin-acetate\/\">Oxytocine Acetaat<\/a> (affiliative-behaviour neuropeptide), and <a href=\"https:\/\/medsbase.com\/nl\/sermorelin\/\">Sermorelin<\/a> (GHRH-axis hypothalamic-pituitary research). Browse the full <a href=\"https:\/\/medsbase.com\/nl\/peptides\/\">onderzoekspeptiden catalogus<\/a> voor gerelateerde verbindingen.<\/p>\n<h2>Beschikbare sterktes en concentraties<\/h2>\n<p>MedsBase stocks Kisspeptin-10 in two lyophilized vial sizes calibrated to typical research protocol lengths. Each strength is available in 10-vial or 20-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Vulsterkte<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typisch Onderzoeksgebruik<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Verpakkingsgroottes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard research strength \u2014 pilot dosing, HPG-axis pulse protocols, single-cohort studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 of 20 flesjes<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended-cycle protocols, multi-cohort studies, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 of 20 flesjes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when researchers want to minimise injection volume in rodent protocols. Because kisspeptin-10 dose ranges are in the low-microgram regime per administration, a single 5\u00a0mg vial supports many weeks of pulse-protocol research at typical doses.<\/p>\n<h2>How It Compares \u2014 Kisspeptin-10 vs PT-141<\/h2>\n<p>Kisspeptin-10 and <a href=\"https:\/\/medsbase.com\/nl\/pt-141\/\">PT-141 (Bremelanotide)<\/a> are both small CNS-active peptides used in reproductive- and sexual-behaviour research, but they act on fundamentally different pathways. Kisspeptin-10 acts on the endocrine HPG axis at the GnRH-neuron level; PT-141 acts on the melanocortin behavioural-sexual axis at the MC4R level. The two are mechanistically complementary rather than competing in research models.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kisspeptine-10<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">PT-141 (Bremelanotide)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lengte<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 amino acids (decapeptide)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino acids (cyclic heptapeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary receptor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GPR54 \/ KISS1R<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MC3R \/ MC4R melanocortin receptors<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary effect<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GnRH\/LH\/FSH release (endocrine)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">CNS-mediated sexual behaviour (behavioural)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Research domain<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">HPG axis, puberty, hypogonadism, IVF<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sexual desire, arousal, erectile function<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Plasma half-life<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~5\u201310 min<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 hours (SC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Approved clinical use<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">None (Phase 2 in IVF research)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">FDA-approved as Vyleesi for HSDD (different molecule from research-grade)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typische onderzoeksdosis<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u2013200\u00a0mcg, bolus or pulse<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">0.25\u20132\u00a0mg, single administration<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The two peptides address different layers of reproductive biology \u2014 kisspeptin-10 the endocrine HPG axis, PT-141 the CNS-mediated behavioural axis \u2014 so they are not direct alternatives. Research interested in pulsatile GnRH\/LH dynamics, puberty timing, or hypogonadism uses kisspeptin-10. Research interested in CNS-mediated sexual-arousal pathways uses PT-141.<\/p>\n<h2>Opslag en Reconstituering<\/h2>\n<p><strong>Voor reconstituering:<\/strong> store lyophilized vials refrigerated at 2\u20138\u00a0\u00b0C in original packaging for short-term working stock. For unopened long-term storage, freeze at \u221220\u00a0\u00b0C. Lyophilized kisspeptin-10 is stable under refrigeration for up to 24 months and at \u221220\u00a0\u00b0C for up to 36 months. Avoid freeze-thaw cycles on the lyophilized powder.<\/p>\n<p><strong>Reconstitueringsprocedure:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg research dose. For lower-dose work, further dilution into bacteriostatic water (with optional BSA carrier protein at 0.1%) can be used. Swirl gently \u2014 do <strong>niet<\/strong> Bewaar gekoeld bij 2\u20138 \u00b0C en gebruik binnen 30 dagen voor optimale stabiliteit. Vries de gereconstitueerde oplossing niet in \u2014 vries-ontdooicycli tasten de peptide-integriteit aan. Gooi elk flesje weg dat troebelheid, neerslag of verkleuring vertoont. Omdat tirzepatide in onderzoeksprotocollen eenmaal per week wordt toegediend, ondersteunt een enkel gereconstitueerd 10 mg-flesje doorgaans 2\u20134 weken dosering, afhankelijk van de doeldosis; een 50 mg-flesje ondersteunt 10\u201320 weken bij klinisch equivalente doseringen.<\/p>\n<p><strong>Na reconstitutie:<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days for optimal stability. Do not freeze the reconstituted solution \u2014 freeze-thaw cycles degrade peptide integrity. Discard any vial showing cloudiness, precipitate, or discolouration. Kisspeptin-10 is susceptible to proteolytic cleavage at the C-terminal RF-amide motif; reconstituted solution should be used promptly within the 30-day window for protocols requiring tight dose-response calibration.<\/p>\n<h2 id=\"faqs\">Veelgestelde vragen<\/h2>\n<h3>What is Kisspeptin-10 used for in research?<\/h3>\n<p>Kisspeptin-10 is used in laboratory research investigating the hypothalamic-pituitary-gonadal (HPG) axis, GnRH neuron activity, pulsatile gonadotropin release, puberty onset, hypogonadotropic hypogonadism, polycystic ovary syndrome (PCOS), IVF and ovulation-induction alternatives to hCG, cancer metastasis suppression (KISS1 was originally identified as a metastasis-suppressor gene), and emerging cardiometabolic kisspeptin signalling. It is the canonical research tool for KISS1R \/ GPR54 pharmacology. The research-grade kisspeptin-10 sold here is <strong>niet<\/strong> FDA-goedgekeurd en wordt strikt geleverd voor laboratoriumonderzoek alleen.<\/p>\n<h3>How is Kisspeptin-10 different from PT-141?<\/h3>\n<p>Both are small CNS-active reproductive peptides, but they target different receptors and biological layers. Kisspeptin-10 acts on the GPR54\/KISS1R receptor on GnRH neurons and drives the endocrine HPG axis (LH, FSH, gonadal steroid production). PT-141 acts on MC3R\/MC4R melanocortin receptors in the CNS and drives behavioural-sexual responses (desire, arousal, erectile function). The two are mechanistically complementary and address different research questions.<\/p>\n<h3>What is the difference between Kisspeptin-10 and Kisspeptin-54?<\/h3>\n<p>Both are active fragments of the KISS1 gene product. Kisspeptin-54 (also called metastin) is the full-length mature 54-amino-acid peptide secreted in vivo. Kisspeptin-10 is the C-terminal 10-amino-acid active core, which retains essentially full receptor potency and is the most commonly used research peptide because its smaller size makes synthesis cheaper, purity easier to verify, and reconstitution simpler. Kisspeptin-13 and kisspeptin-14 are intermediate cleavage products that also share the active C-terminal core. All four have comparable potency at GPR54.<\/p>\n<h3>What is the typical Kisspeptin-10 research dose?<\/h3>\n<p>Published preclinical protocols typically use 10\u2013200\u00a0mcg per administration in rodent models, given subcutaneously or intravenously for bolus-pulse research, or as continuous infusion for chronic-stimulation studies. Human IVF research has used 6.4\u201312.8\u00a0\u03bcg\/kg as a single subcutaneous trigger dose. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 0.04\u00a0mL equals 100\u00a0mcg.<\/p>\n<h3>Is Kisspeptin-10 FDA approved?<\/h3>\n<p>No. Kisspeptin-10 is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. Phase 2 clinical research in IVF ovulation induction is ongoing, but kisspeptin-10 has not been approved for any clinical indication. All kisspeptin-10 sold by research-use-only suppliers is for laboratory investigation and should not be administered to humans.<\/p>\n<h3>How should Kisspeptin-10 be stored?<\/h3>\n<p>Lyophilized vials: refrigerated at 2\u20138\u00a0\u00b0C for short-term working stock, or \u221220\u00a0\u00b0C for long-term storage of unopened vials. Reconstituted solution: refrigerated at 2\u20138\u00a0\u00b0C, use within 30 days. Do not freeze reconstituted solution \u2014 freeze-thaw cycles degrade the peptide. Protect from direct light at all times. For low-concentration working dilutions, BSA carrier protein (0.1%) is recommended to minimise adsorption losses.<\/p>\n<h3>How do I reconstitute Kisspeptin-10?<\/h3>\n<p>Volg de hierboven beschreven reconstitutieprocedure. Voeg bacteriostatisch water toe langs de zijkant van het flesje (niet rechtstreeks op het gevriesdroogde poeder), draai voorzichtig en laat 2\u20135 minuten staan voor volledige oplossing. Schud <strong>niet<\/strong> Schud het flesje. Een correct gereconstitueerde oplossing is helder en kleurloos. Voor een flesje van 5 mg + 2,0 mL verdunningsmiddel is de werkconcentratie 2,5 mg\/mL.<\/p>\n<h3>Welke sterktes heeft MedsBase op voorraad?<\/h3>\n<p>MedsBase carries Kisspeptin-10 in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial or 20-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request.<\/p>\n<h3>Why was KISS1 originally named kisspeptin?<\/h3>\n<p>The KISS1 gene was discovered as a metastasis-suppressor gene by Lee et al. at Hershey, Pennsylvania (Cancer Res 1996). The name &#8220;kisspeptin&#8221; was a tongue-in-cheek reference to Hershey&#8217;s Kisses, the iconic chocolate produced in the same town. The reproductive role was not characterised until 2003 with the simultaneous publication of human GPR54-mutation hypogonadism studies in NEJM (Seminara et al.) and PNAS (de Roux et al.). The peptide thus has the unusual distinction of being independently characterised as both a cancer metastasis suppressor and the apical regulator of puberty \u2014 two roles that remain incompletely connected mechanistically.<\/p>\n<h3>Does Kisspeptin-10 cause side effects in research?<\/h3>\n<p>Published preclinical and Phase 1\/2 clinical research has documented good tolerability at typical research doses. The predominant on-target effects are HPG-axis activation \u2014 rising LH, FSH, testosterone (males) or estradiol (females), and downstream gonadal steroid effects. Off-target findings include modest cardiovascular effects mediated by KISS1R expression on vascular tissue, and a flushing\/vasodilation effect noted in some human research at higher doses. Long-term safety data outside research contexts is limited.<\/p>\n<h3>What is the half-life of Kisspeptin-10?<\/h3>\n<p>In preclinical and clinical research, kisspeptin-10 has a plasma half-life of approximately 5\u201310 minutes following intravenous or subcutaneous administration. The short half-life is due to rapid proteolytic cleavage by matrix metalloproteinases at the central RF-amide motif. For chronic-stimulation research, continuous infusion or repeated pulse-dosing protocols are used to maintain receptor occupancy.<\/p>\n<h3>How long does Kisspeptin-10 take to show effects in preclinical research?<\/h3>\n<p>Acute LH responses to bolus kisspeptin-10 administration are detectable within 5\u201315 minutes in rodent and human research. FSH and downstream gonadal steroid responses develop over hours to days. Chronic-stimulation effects on puberty timing in young rodent models manifest over the natural pubertal window \u2014 days to weeks depending on species and developmental stage at intervention.<\/p>\n<h3>Can I order Kisspeptin-10 for international shipping?<\/h3>\n<p>Yes. MedsBase ships Kisspeptin-10 worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. All orders ship in temperature-controlled packaging with full tracking and are covered by our <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Reproductive, CNS, and Behavioural Research<\/h2>\n<ul>\n<li><a href=\"\/nl\/pt-141\/\"><strong>PT-141 (Bremelanotide)<\/strong><\/a> \u2014 Cyclic heptapeptide melanocortin agonist \u2014 CNS-mediated sexual-behaviour research<\/li>\n<li><a href=\"\/nl\/oxytocin-acetate\/\"><strong>Oxytocine Acetaat<\/strong><\/a> \u2014 9-aa cyclic neuropeptide \u2014 social-bonding and affiliative behavioural research<\/li>\n<li><a href=\"\/nl\/sermorelin\/\"><strong>Sermorelin<\/strong><\/a> \u2014 GHRH(1-29) analog \u2014 hypothalamic-pituitary-axis research<\/li>\n<li><a href=\"\/nl\/cjc-1295-with-dac\/\"><strong>CJC-1295 met DAC<\/strong><\/a> \u2014 Long-acting GHRH analog \u2014 growth-axis research<\/li>\n<li><a href=\"\/nl\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide \u2014 GABA \/ BDNF stress-resilience research<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Verder lezen<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore reproductive and CNS-active research peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Bekijk het volledige <a href=\"https:\/\/medsbase.com\/nl\/peptides\/\"><strong>onderzoekspeptiden catalogus<\/strong><\/a>, met verwante verbindingen inclusief <a href=\"https:\/\/medsbase.com\/nl\/pt-141\/\">PT-141 (Bremelanotide)<\/a> for melanocortin sexual-behaviour research, <a href=\"https:\/\/medsbase.com\/nl\/oxytocin-acetate\/\">Oxytocine Acetaat<\/a> for affiliative-behaviour research, and <a href=\"https:\/\/medsbase.com\/nl\/sermorelin\/\">Sermorelin<\/a> for hypothalamic-pituitary-axis research.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Apical regulator of GnRH neuron activity<br \/>\n\u2705 KISS1R \/ GPR54 receptor agonist<br \/>\n\u2705 HPG-axis &amp; puberty research compound<br \/>\n\u2705 IVF and ovulation-induction research<br \/>\n\u2705 Originally identified as metastasis suppressor<\/p>\n<p><strong>Kisspeptine-10<\/strong> bevat synthetisch peptideverbinding.<\/p>","protected":false},"featured_media":70963,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6277,5441],"class_list":{"0":"post-70723","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-kisspeptin","8":"product_tag-peptide","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product\/70723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/comments?post=70723"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media\/70963"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media?parent=70723"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_brand?post=70723"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat?post=70723"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_tag?post=70723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}